The G-NeSS Registry prospectively collects data on clinical and outcome variables from patients undergoing partial nephrectomy for renal masses. Analyses of data aims at identifying key factors determining the quality of surgical care in this patient population.
Today the majority of patients with renal tumors is diagnosed with localized disease amenable to nephron-sparing surgery (NSS). Partial nephrectomy (PN) constitutes the reference standard treatment for small renal masses according to international guidelines. Open PN ist still the predominant apporach in Germany, but the use of minimally-invasive surgery has continously increased over the last decades. Specifically, robotic surgery is on the rise and may facilitate the adoption of a minimally-invasive PN approach even in more complex renal tumours. Real world data on the outcomes of PN according to the surgical approach are limited. Data from cancer registries and health insurance databases usually lack important information an key patient und tumour characteristics, such as tumour complexity. The G-NESS registry database aims at prospectively collecting such clinical and outcome data from patients undergoing PN. Data collection includes perioperative variables on patient characteristics, tumour location and complexity, surgical approach, intra-/postoperative complications, and kidney function. Follow-up based on questionnaires is conducted after predefined intervals (i.e. 30 days, 12 months, 24 months, and 60 months) in order to receive information on long-term kidney function, comorbidities, and survival. The information received from the database can help to better define the optimal surgical care for patients with renal masses.
Study Type
OBSERVATIONAL
Enrollment
1,000
Observation only
Sana Klinikum Hof
Hof, Bavaria, Germany
RECRUITINGMHH
Hanover, Lower Saxony, Germany
RECRUITINGAlexianer St. Hedwig-Krankenhaus
Berlin, Germany
RECRUITINGComplication rate
Complication rate according to Clavien-Dindo in %
Time frame: 60 months
Postoperative glomerular inflitration rate
Rate in ml/min.
Time frame: 60 months
Survival
Overall Survival
Time frame: 60 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Vivantes Humboldt Klinikum
Berlin, Germany
RECRUITINGSaarland University
Homburg/Saar, Germany
NOT_YET_RECRUITING